Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Peter Trainer(University of Manchester), John A. Scarlett(International Drug Development), A.J. van der Lely(Rotterdam University of Applied Sciences), D. Roderick Rose, Suzanne Hackett, Craig Parkinson, Vivien Herman-Bonert(Cedars-Sinai Medical Center), Eleni V. Dimaraki(University of Michigan), Jeffrey S. Powell, Michael O. Thorner(Ames National Laboratory), Christian J. Strasburger(Humboldt-Universität zu Berlin), Paul M. Stewart(University of Leeds), Gudmundur Johannsson(Sahlgrenska University Hospital), Martin Bidlingmaier(LMU Klinikum), Lawrence S. Phillips(Emory University), Kenneth Zib, David L. Kleinberg(New York University), Ariel L. Barkan(University of Michigan), William F. Bennett, Robert J. Davis(University of Verona), David M. Cook, Laurence Katznelson(Stanford University), Stavros Stavrou, William M Drake(St Bartholomew's Hospital), Bengt‐Åke Bengtsson(Sahlgrenska University Hospital), Mary Lee Vance(University of Virginia), Michael C. Sheppard(University of Virginia), G. M. Besser(St Bartholomew's Hospital), Keith Friend(South Australia Pathology), Anne Klibanski(Mass General Brigham), David R. Clemmons(University of North Carolina at Chapel Hill), Mario Maldonado, Pamela U. Freda(Columbia University)
Cited by 874
Related Papers
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
|New England Journal of Medicine|2006|985
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
|Endocrine Reviews|2000|817
Selective oxidation of alcohols and aldehydes over supported metal nanoparticles
|Green Chemistry|2012|777